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Differential mobility analysis (DMA) is a technique suited for size analysis as well as
preparative collection of airborne nanosized airborne particles. In the recent decade, the
analysis of intact viruses, proteins, DNA fragments, polymers, and inorganic nanoparticles
was possible when combining this method with a nano-electrospray charge-reduction source
for producing aerosols from a sample solution/suspensions. Mass analysis of high molecular
weight noncovalent complexes is also possible with this methodology due to the linear
correlation of the electrophoretic mobility diameter and the molecular mass. In this work, we
present the analysis (size and molecular mass) of high molecular weight multimers (nonco-
valent functional homocomplex) of Jack bean urease in a mass range from 275 kDa up to 2.5
MDa, with mainly present tri- and hexamers but also higher oligomers of the 91 kDa monomer
subunit. In a second experiment, the size analysis of intact very-low-density (35 nm),
low-density (22 nm) and high-density lipoparticles (10 nm), which are heterocomplexes
consisting of cholesterol, lipids, and proteins in different ratios, is presented. Results from
mobility analysis were in excellent agreement with particle diameters found in literature. The
last presented experiment demonstrates size analysis of a rod-like virus and selective sampling
of a selected size fraction of electrosprayed, singly-charged tobacco mosaic virus particles.
Sampling and subsequent transmission electron microscopic investigations of a specific size
fraction (40 nm electrophoretic mobility diameter) revealed the folding of virus particles
during the electrospray and charge reduction (electrical stress) as well as solvent evaporation
(mechanical stress) process, leading to an observed geometry of 150 (length)  35 (width) nm
(average cylindrical geometry of unsprayed intact virus 300  18 nm). (J Am Soc Mass
Spectrom 2008, 19, 1062–1068) © 2008 American Society for Mass SpectrometryNoncovalent interactions of proteins are of greatinterest as they play a vital part in biology andmedicine such as blood coagulation, gene expres-
sion [1, 2], immune recognition [3], and formation of
lipoparticles [4] and viruses. Analysis of the formation
process, stoichiometry, and molecular weight of those
complexes can be very challenging as noncovalent inter-
actions can easily be destroyed or biased when leaving
specific native conditions [5], and as their molecular mass
can easily exceed the working range of modern mass
spectrometry. For these reasons, a demand for new ana-
lytical techniques, which preserve noncovalent interac-
tions, deliver molecular mass and/or size related informa-
tion (in contrast to capillary electrophoresis and native gel
electrophoresis) and which have a working range that
exceed conventional mass spectrometry, exists.
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doi:10.1016/j.jasms.2008.05.017Differential mobility analysis (DMA) is a technique
developed to classify charged aerosolized particles un-
der ambient pressure according to their electrophoretic
mobility diameter [6]. In the recent decade, its working
range was extended from m down to the nm size
range [7], or in terms of molecular mass, into the kDa to
GDa molecular mass range, thus closing the gap be-
tween classic aerosol particle technology (low m into
mm range) and mass spectrometry (sub-nm to 10 nm).
The size range of 10 to 200 nm is therefore of great
interest, and covered by the so-called nano-differential
mobility analysis (nano DMA) [8]. Combined with a
modified nano electrospray source (nES) for nanoaero-
sol generation, and bipolar charging process to deliver
mostly singly charged ions [9, 10], it has been demon-
strated that the analysis of intact biospecific protein
complexes [11, 12], viruses [11], virus antibody [13],
virus receptor [13], bacterio phages [14], and polymers
[15, 16] is possible, and delivers a lot of new knowledge.In this work, we present new interesting applications
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namely nES gas-phase electrophoretic mobility molec-
ular analyzer (GEMMA) and parallel DMA (PDMA).
Briefly, the GEMMA system [8, 11] is based on the
electrospraying of the sample solution by means of
voltage and supported by sheath gas flow of particle-
free air and CO2 followed by charge reduction via a
bipolar atmosphere (generated by a polonium-210
source) of the multiple charged aerosol particles to
singly positive or negative charged particles/ions (ap-
proximately 1% of all aerosolized particles) and a huge
number of neutral particles (approximately 99%). These
ions are transferred to the nano DMA (a particular form
of an ion mobility spectrometer operated at atmo-
spheric pressure) where the charged nanobioparticles
are separated according to their electrophoretic mobil-
ity in a laminar flow of particle free air (several L/min
of air flow) with an orthogonal voltage scan. The size-
separated charged particles are transferred to the detector,
which in the case of GEMMA is a condensation particle
counter based on direct optical detection of particles.
The PDMA consists of the same components except that
the detector is a Faraday cup detector (due to faster
response time compared with condensation particle
counter detectors), and a collector unit is attached (see
Figure 1a). The source of singly charged particles and
the way they are generated are identical to the GEMMA
system. Afterwards the airborne charged particles are
Figure 1. Schematic of the nano ES (aerosol so
system (a) used, consisting of a scanning nan
sampling nano DMA (collector DMA with EP
electrostatic particle (EP) sampler (c).either for a short time completely transferred into the
scanning nano DMA and a complete size spectrum is
obtained with the Faraday cup detector (Figure 1b.)
Afterwards the operator selects a peak or size of
interest and the correlating scan voltage is automat-
ically transferred to the sampling nano DMA with
attached electrostatic particle sampler (Figure 1a and
c). By applying a certain voltage in the sampler, the
size-separated charged particles are deflected to the TEM
grid (Figure 1c).
First, we show the GEMMA analysis of the high
mass functional biocomplex of urease (isolated from
jack bean), which is known to form multimers up to 3
MDa molecular mass [17, 18]. The biologically relevant
complex is a hexameric particle consisting of six iden-
tical proteins (molecular weight 90.77 kDa, Swiss-Prot
entry P07374) resulting in a particle with a molecular
mass of 544.62 kDa, which is an example of a metallo-
enzyme containing 12 nickel atoms. The second exam-
ple shows the particle size analysis of intact high
density (HDL), low density (LDL), and very low density
(VLDL) lipoprotein particles [4] isolated from human
plasma and ranging in size from 7 to 120 nm. This
functional biocomplex is of particular interest because it
consists not only of different proteins (heterocomplex)
but contains also a huge amount of lipid molecules,
namely triglycerides, cholesterol and its ester, and
phospholipids. The analysis of blood concentration as
PDMA (parallel differential mobility analyzer)
A (analytical DMA with FC detector) and a
ler), a Faraday cup (FC) detector (b), and anurce)
o DM
samp
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of great diagnostically importance for assigning the risk
of cardiovascular and other lipid-connected health risks
[23]. A recently granted U.S. patent indicates the use of
GEMMA for a medical application in this field [24], and
a brief mention was also given in a recent review article
by Kaddis and Loo [8]. Furthermore, many subfractions
of these particles (e.g., IDL or chylomicrons) were
identified by analytical techniques such as NMR spec-
troscopy, gel electrophoresis, and vertical auto-profiling
(ultracentrifugation), which allow the quantification of the
various lipoparticles as a function of their size [23]. In
the last application, the analysis and sampling of cylin-
drical (approximately 300 (length)  18–20 nm (o.d.)
with an inner channel of approximately 4 nm) tobacco
mosaic virus (TMV) particles [25]—an RNA virus that
infects plants, especially members of the family So-
lanaceae, and is composed of proteins, viral RNA and
other small molecules—by means of a parallel DMA
(which is an extension of the GEMMA system applied
for the previous two applications) is presented.
Experimental
Materials
HDL, LDL, and Jack bean (Canavalia ensiformis) urease
were purchased from Sigma-Aldrich (L8039, L7914,
U1500; St. Louis, MO). HDL (-lipoprotein) and LDL
(-lipoprotein) were isolated from human plasma by
ultracentrifugation and obtained in 150 mM sodium
chloride with 0.01% EDTA (pH 7.4) solution. VLDL
(pre--lipoprotein) was provided by the working group
of D. Blaas (Medical University of Vienna) after ultra-
centrifugation. TMV samples were provided by the
group of F. L. Dickert (University of Vienna). All
samples were purified to remove or reduce involatile
additives via dialysis against a 20 mM ammonium
acetate buffer solution (pH 6.5), which was prepared
from distilled water and analytical grade ammonium
acetate for mass spectrometry (73,594; Sigma-Aldrich,
St. Louis, MO). All samples (urease and lipoparticles)
were diluted to a final concentration of about 50 g/mL
by means of the mentioned ammonium acetate solution
to avoid unspecific dimer and oligomer formation [7].
TMV samples, ready for spraying, had a concentration
of approximately 100 g/mL. In case of the urease,
even lower concentrations were used to verify the
specificity of hexameric complex formation. The inter-
nal calibrant for the urease experiments was an
immunoglobulin G (Octapharma, Vienna, Austria)
analyzed by SDS-PAGE, capillary gel electrophoresis-
on-the-chip and MALDI mass spectrometry (in terms
of homogeneity and molecular mass).
n-ES Conditions for GEMMA and PDMA
The nano-electrospray (n-ES) source (aerosol source,
model 3480; TSI Inc, Shoreville, MN) was operated with1.8 kV positive polarity. The sample liquid was forced
through the capillary (40 m i.d.) with a pressure
difference of 4 psi resulting in a flow of 70 nL/min
sample flow. A sheath flow of 1 L/min compressed air
and 0.4 L/min CO2 (Air Liquide, 99.995%) was set to
prevent corona discharge at the tip of the spray needle
and to achieve a stable spray in the necessary cone jet
mode [26]. A Po210  radiation source (5 mCi, model
P-2042 Nucleospot local air ionizer; NRD, Grand Island,
NY) is embedded in the nano ES source and leads to a
bipolar charging atmosphere. The highly charged nano-
droplets, generated via electrospray process in the
cone-jet mode, were transformed in the bipolar atmo-
sphere into neutral and singly positively and negatively
charged particles [9, 10]. The so generated particles are
transferred into the separation device (nano DMA in
case of GEMMA or scanning nano DMA/sampling
nano DMA in case of PDMA system).
GEMMA and PDMA
GEMMA. The differential mobility analyzer [7]
(model 3980; TSI Inc for a more detailed description see
www.tsiinc.de/documents/3980C.pdf) was operated in
a sizing range between 3 and 67 nm with 15 L/min
sheath air to achieve maximum resolution of 20. The
central electrode was operated with negative polarity,
thus analyzing the singly positively charged particle
fraction. The classified [separated according to their
electrophoretic mobility (EM) diameter)] particles were
detected with a condensation particle counter (model
3025; TSI Inc.) suited for single particle detection, re-
sulting in a limit of detection of about 103 particles/cm3
aerosol.
PDMA. For the experiments with the TMV tobacco
mosaic virus, a parallel DMA (PDMA) [27] system
(Figure 1a) was used and the setup consisting of two
identical in-house built nano DMAs, one connected
with an in-house built classic Faraday cup (FC) detector
[28] (Figure 1b) and the other with a self-assembled
electrostatic particle (EP) sampler (Figure 1c). Both nano
DMAs, one, the scanning (scan voltage from 10 V to 10
kV) nano DMA, for obtaining a complete size spectrum,
and the other, the sample nano DMA on a specific
central voltage, for selecting a particular size range (in
this case 40 nm), which is of interest and leads subse-
quently to the sampling/collecting of a specific particle
size fraction. Both nano DMAs were operated with 20
L/min sheath gas flow and a starting size of 10 nm.
Sampling Device of PDMA
The in-house built EP sampler [29] (Figure 1c) suited for
sampling nanometer sized particles was operated with
2 kV deflection voltage applied to a transmission elec-
tron microscopy (TEM) grid (BalTec S160, 3 mm diam-
eter, 20 nm carbon film). The ES sampler was positioned
in sequence closely to the exit of the sampling nano
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the classified size fraction. For TMV sample, a collection
time of 2 h was applied. Afterwards, the TEM grid with
the collected TMV was removed from the EP sampler
and TEM images were obtained by means of a Philips
CM12 electron microscope. With the same microscope
and under identical conditions, the TMV solution be-
fore introduction into the PDMA system was analyzed.
Results and Discussion
High Molecular Mass Noncovalent Protein
Complex
The GEMMA spectrum of jack bean urease (Figure 2)
shows various clearly distinguishable peaks. The first
peak at 9.6 nm corresponds to an internal calibrant (im-
munoglobulin G). This size corresponds to 148 kDa mo-
lecular mass when applied to an external protein-based
calibration [11], which is practically identical to the theo-
retical value within the confidence interval of the calibra-
tion curve (R2  0.996). We want to mention that the
calculation of the molecular mass for proteins and com-
plexes below two million Da is based on the following
validated correlation: M (EMD, )  (  EMD3/6) 
  NA, M, molecular mass; EMD, electrophoretic
mobility diameter; , density of particle/ion; NA,
Avogardo’s number [8, 11]. Thus, no further correction
of the molecular mass analysis of the noncovalent
complexes of urease was necessary. At 11.7 nm, the first
peak attributable to urease appears. This diameter value
corresponds to a molecular mass of 275 kDa ([3M]), or
to a trimer of the 91 kDa [17] monomer of urease (also
known as the so-called A1 unit). The most abundant
peak in the GEMMA spectrum at 14.7 nm ([6M])
corresponds to an intact hexameric urease (spherical
so-called -unit at 560 kDa compared with the theoret-
ical value of 546 kDa. This result matches well with
Figure 2. GEMMA spectrum of the noncovalent homocomplex
of Jackbean urease (50 g urease/mL). Besides the dominating
hexameric ([6M]) complex, a nonamer ([9M]), as well as unre-
solved oligomers are present and a trimer corresponding to [3M]
or [6M]2. An internal calibrant (immunoglobulin G) was added
to the urease solution.literature, where experiments have shown that urease
forms tri- and hexamers, under certain conditions with
the hexamer as the dominant biological active form
under physiological conditions and the trimer as a
intermediate before complete dissociation, for example
at high or low pH [18]. Low abundant but not well-
resolved peaks appear at 16.8 nm and between 18 and
22.5 nm, corresponding to [9M] and [12–30 M] ag-
gregates, indicating that urease might have a tendency
to form less abundant high molecular weight complexes
formed from the more stable trimeric and hexameric
particles. How far these high molecular mass aggre-
gates are of biological importance cannot be said at this
point but might be of value for future investigations of
functional protein complexes. The GEMMA tool might
give indications for complexes, which could not be
detected by other techniques as size exclusion chroma-
tography or analytical ultracentrifugation due to the
low sensitivity of these techniques.
Lipoprotein Particles
In Figure 3 the GEMMA size spectra of VLDL, LDL, and
HDL are shown. VLDL is composed of 50% triacylglyc-
erols, 20% phospholipids, 10% cholesterinesters, and
10% proteins [4]. The function of VLDL is the transport
of lipids from liver to peripheral organs directly after
the digestion process and is converted afterwards to
LDL. As can be seen, the size spectrum of VLDL shows
a broad size distribution between 27 and 50 nm, with a
maximum at about 35 nm, which agrees well with
values found in literature [4, 30]. The broad distribution
correlates to the task of transporting endogenous lipids.
LDL particles contain 10% triacylglycerines, 20% pro-
teins, 20% phospholipids, and 40% cholesterinesters,
and functions as a fast accessible cholesterin reservoir.
From medical studies, it is known that its average size
Figure 3. OverlaidGEMMAspectra of three different types of human
lipoprotein particles at a concentration of 50 g lipoparticles/mL (high
density lipoprotein, low density lipoprotein, and very low density
lipoprotein nanoparticle).and blood level are possible predictors for cardiovascu-
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tion contained within the LDL particles) and that the
abundance of a small, dense subfraction are an indica-
tor for arthrogenic dyslipidemia [31]. The GEMMA
analysis shows, compared with VLDL, a narrow size
distribution with an average size of 21.7 nm, which also
corresponds well with data (22 nm) from literature [4,
23]. HDL is the densest lipoparticle due to the highest
percentage of proteins and smallest in size containing
50% proteins, 25% phospholipids, and 15% cholester-
inesters. Its function is to collect excess cholesterol from
the periphery and to deliver it at the liver or release it
for the production of steroid hormones [4]. Its particle
size varies between 8 and 11 nm, with a correlation
between cholesterol levels and HDL size [32]. The
GEMMA size spectrum shows a sharp peak at 10 nm,
which is also in agreement with literature data [4, 32]. In
the medical field, exact and fast size determination of
lipoparticles and their subspecies might be used for
deeper understanding of lipid biochemistry in humans
and health risk assessment [8c, 24] instead of indirect
techniques as the Friedewald method [33] or other in
the introduction mentioned sophisticated and time-
consuming methods. This example might be helpful
and inspiring to investigate various kinds of sophisti-
cated drug delivery systems, e.g., liposomes, dendrim-
ers [15], or cell compartments.
Collection of Intact Tobacco Mosaic Virus
Before we start a brief description of the operation of
the PDMA system, we give the major reasons for the
construction and use of this device. First, due to the
facts that the system is operated at atmospheric pres-
sure and in a continuous mode (electrospraying and
charge reduction was tested successfully up to 24 h), a
collection of separated singly charged bioparticles
(ions) seems to be of general interest for subsequent
analysis (e.g., TEM of the size-selected particles). A
critical factor for optimal and reproducible separation
of particles/ions by means of a nano DMA in general is
Figure 4. The TEM image of diluted TMV solut
from scanning/analytical nano DMA with FC de
DMAwas operated at the EM diameter maximum
collected by the EP sampler after collector nano DMAthe laminar air flow, particularly if done over long time
periods [6–8]. Therefore, an analytical (scanning) nano
DMA and a collector (sampling) nano DMAwere run in
parallel (Figure 1a), splitting the stream of singly
charged bioparticles (coming from the nano ES) before
entering the nano DMAs to guarantee identical flow
conditions in the scanning (analytical) nano DMA and
sampling (collector) nano DMA. The analytical nano
DMA with the Faraday cup detector (Figure 1b) is
continuously scanning the whole size range (indicating
any changes in the size spectrum of the electrosprayed
sample) and the determined maximum in size (at a
particular DMA voltage) is transferred after selection by
operator automatically to the sampling nano DMA.
Then, the whole stream of singly charged particles
flows into the sampling nano DMA (and at certain time
points the stream of particles is switched back to the
scanning nano DMA for checking the full size spectrum
of the sample). So the collector nano DMA allows only
the passage of charged particles with the selected par-
ticular size, which, after leaving the central electrode of
the DMA, are collected by the EP sampler (Figure 1c). A
perpendicular (to the flow direction of the aerosol flow)
electrical field directs the separated charged particles
onto the TEM grid. Afterwards, the grid with the
attached size-selected particles can be removed for
further investigations. This experimental procedure is il-
lustrated with a solution of a rod-shaped virus (TMV). In
Figure 4a, the TEM image (staining with uranylium acetate)
of a diluted aqueous ammonium acetate-containing TMV
solution exhibits a sharp, black colored shell of the
virus. As was derived from the picture, the virus
particles possess a uniform thickness of 18 nm o.d.,
which corresponds with the known viral structure [34].
The length of the observed viral particles varies signif-
icantly (from a length from 120 up to 1000 nm). It is
known that the intact virus particle possesses an aver-
age length of about 300 nm and the shorter TMV
particles are probably either unfinished or, through the
isolation process from cell culture, destroyed. Longer
TMV particles seem to be more than one TMV particle
00 g/mL) before analysis (a). PDMA spectrum
r of TMV. The PDMA sampling (collector) nano
he hatched area (b). The TEM image of the TMVion (1
tecto
of tpassage (c).
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sharp bends that appear along the length of these
particles. Size analysis of the TMV virus by means of the
PDMA (Figure 4b) shows two relatively broad peaks
(bimodal distribution), with a maximum at 40 (arrow in
Figure 4b) and 60 nm. Based on the length distribution
of the stock solution that was electrosprayed, it can be
assumed that the peak at 40 and 60 nm cannot be easily
correlated with sizes of the TEM analysis done on the
starting solution. The bimodal size distribution at 40 nm
might represent single and at 60 nm particles consisting
of two or more attached viruses (which can be seen
TEM image of starting solution Figure 4a). To investi-
gate this working hypothesis, the size fraction at 40  2
nm was selected (by means of collector nano DMA)
with the PDMA for deposition on an electron micro-
scopic grid. TEM analysis of the sampled size fraction
(Figure 4c) shows relatively uniform structures with
much less contrast than the intact TMV particles, lead-
ing to the assumption that the protein shell was injured
and the uranylium acetate as staining substance was
able to enter the viral shell leading to a more uniform
staining of the viral particles. Size analysis (via the TEM
image) of the deposited particles leads to dimensions of
150  12 nm (length)  35  4 nm (width of the
nanobioparticle in the plain of the TEM grid), with most
particles showing a small edge at the half of the shorter
side. After a closer look at the dimensions, it is apparent
that the length is half of the length and the diameter
double the diameter of an intact single TMV particle. This
observation and the small edge in the middle of the
width lead to the conclusion that the sampled virus
particles are indeed single TMV particles, which were
folded in the middle, probably during the electrospray
and water evaporation step, which may lead, as the
droplets containing the TMV particles are getting
smaller, to a bending of the rod-like particles, until the
forces are high enough to break or bend them in the
middle. A similar behavior was also described by
Hogan et al. [14b] for the bacteriophages T2 and T4,
but with the consequence that these nanobioparticles
were broken apart. This experiment demonstrates
that singly charged bioparticles as viruses can be
size-separated and collected by means of the PDMA
system and used for further investigations. This
proof-of-principle experiment corroborates the exper-
iments of Siuzdak et al., demonstrating the viability
of TMV and rice yellow mottle virus after ESI and
passage of a quadrupole analyzer (vacuum system)
with subsequent soft collection by means of a gelati-
nous layer [35]. It will open up new avenues of
research (in terms micropreparative collection) in a
number of fields, where the integrity and viability of
nanobioparticles are of importance (e.g., drug carrier
or vaccine particles). The use of such a device in the
emerging field of nanotechnology, e.g., high-resolution
size-fractionation (and simultaneous analysis) of carbon
nanotubes, quantum dots, or titanium dioxide particles
may open up new possibilities when considering mas-sive parallel nano electrospraying with efficient charge
reduction [36].
Conclusions
The presented applications show that differential ion
mobility/GEMMA analysis is indeed suited to analyze
high molecular weight noncovalent complexes and
complex distributions, which are in a molecular mass
regime not accessible to mass spectrometry with high
accuracy. Furthermore, this technique is able to deter-
mine the size and size distribution of intact lipoprotein
particles and subspecies, which are nanobioparticles of
quite heterogenous composition, in a more convenient
way than in actual medical diagnosis, where their size is
mainly determined routinely by the mentioned Friede-
wald method [33]. Additionally it has been demon-
strated that it is possible to analyze nanobioparticles as
tobacco mosaic virus particles, and to collect a specific
size fraction out of the rather polydisperse sample
containing finished, unfinished, or degraded and at-
tached virus species with the PDMA system. The TEM
analysis of the sampled size fraction showed great
uniformity of the collected viral particles and could
actually—a rather unexpected result—reveal that the
tobacco mosaic virus was folded during the electros-
pray and droplet drying process. This result is caused
by, to a certain extent in a mechanical way [14b], TMV
folding into half and not simply letting both ends
protrude from the droplet surface during droplet evap-
oration (TMV length of 300 nm and a diameter of 18 nm
compared with 160 nm average droplet diameter at the
beginning). The experiments clearly show that singly
charged nanobioparticles (e.g., rod-like and spherical
viruses, lipoparticles, or functional protein complexes)
can be collected by means of the PDMA system and
used for further analysis. The development of multi-
nano ES capillary sources with a replacement of the
radioactive source by a corona discharger [36] and nano
DMAs with improved resolving power [37] might sup-
port the future development of GEMMA and PDMA as
analytical as well as micropreparative tools.
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